Foundry Partners’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,325
Closed -$219K 283
2024
Q3
$219K Sell
3,325
-225
-6% -$14.8K 0.01% 280
2024
Q2
$328K Hold
3,550
0.02% 268
2024
Q1
$339K Sell
3,550
-205
-5% -$19.6K 0.02% 248
2023
Q4
$286K Hold
3,755
0.02% 262
2023
Q3
$260K Sell
3,755
-645
-15% -$44.7K 0.02% 270
2023
Q2
$415K Hold
4,400
0.03% 257
2023
Q1
$364K Hold
4,400
0.02% 267
2022
Q4
$328K Sell
4,400
-1,094
-20% -$81.6K 0.02% 263
2022
Q3
$454K Sell
5,494
-224
-4% -$18.5K 0.03% 246
2022
Q2
$544K Sell
5,718
-3,938
-41% -$375K 0.03% 239
2022
Q1
$1.14M Hold
9,656
0.06% 225
2021
Q4
$1.25M Hold
9,656
0.04% 242
2021
Q3
$1.09M Sell
9,656
-1,303
-12% -$147K 0.04% 260
2021
Q2
$1.14M Buy
10,959
+200
+2% +$20.7K 0.04% 272
2021
Q1
$900K Hold
10,759
0.03% 349
2020
Q4
$982K Buy
10,759
+2
+0% +$183 0.04% 330
2020
Q3
$859K Hold
10,757
0.04% 326
2020
Q2
$743K Sell
10,757
-1,456
-12% -$101K 0.04% 324
2020
Q1
$768K Sell
12,213
-411
-3% -$25.8K 0.04% 319
2019
Q4
$982K Sell
12,624
-558
-4% -$43.4K 0.04% 322
2019
Q3
$966K Sell
13,182
-1,911
-13% -$140K 0.04% 319
2019
Q2
$929K Buy
15,093
+1,050
+7% +$64.6K 0.04% 325
2019
Q1
$896K Hold
14,043
0.04% 323
2018
Q4
$717K Buy
14,043
+312
+2% +$15.9K 0.03% 327
2018
Q3
$797K Buy
13,731
+4,848
+55% +$281K 0.03% 335
2018
Q2
$431K Sell
8,883
-204
-2% -$9.9K 0.02% 351
2018
Q1
$423K Buy
9,087
+198
+2% +$9.22K 0.02% 356
2017
Q4
$334K Sell
8,889
-171
-2% -$6.43K 0.01% 360
2017
Q3
$330K Hold
9,060
0.01% 366
2017
Q2
$357K Sell
9,060
-5,235
-37% -$206K 0.01% 383
2017
Q1
$448K Sell
14,295
-3,150
-18% -$98.7K 0.02% 374
2016
Q4
$545K Sell
17,445
-20,661
-54% -$645K 0.02% 373
2016
Q3
$1.53M Sell
38,106
-294
-0.8% -$11.8K 0.08% 283
2016
Q2
$1.28M Sell
38,400
-3,465
-8% -$115K 0.07% 293
2016
Q1
$1.23M Buy
+41,865
New +$1.23M 0.12% 186